Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

Primer: Hyundai Movex (319400 KS) - Jan 2026

An Early Look at Potential Additions and Deletions to KOSDAQ150 in June 2026

An Update on the KOSPI 200 Rebalance Candidates in June 2026

Douglas Research Advisory

Index Rebalance

<ul>
<li>This insight provides an update on the KOSDAQ 150 rebalance candidates in June 2026.</li>
<li>I provide 8 potential addition candidates to KOSDAQ 150 rebalance including Orum Therapeutics (475830 KS), Hyundai Movex (319400 KS), and Rokit Healthcare (376900 KS). </li>
<li>These 8 stocks are up on average 130.3% in the past six months, significantly outperforming KOSDAQ which is up 31.5% in the same period.</li>
</ul>


This insight provides an update on the KOSDAQ 150 rebalance candidates in June 2026.
I provide 8 potential addition candidates to KOSDAQ 150 rebalance including Orum Therapeutics (475830 KS), Hyundai Movex (319400 KS), and Rokit Healthcare (376900 KS). 
These 8 stocks are up on average 130.3% in the past six months, significantly outperforming KOSDAQ which is up 31.5% in the same period.


2026年6月のKOSDAQ 150銘柄のリバランス候補に関する最新情報